To register for the presentation, please follow this Zoom link: https://us02web.zoom.us/webinar/register/WN_Nx3kCIIOSmOj686nctwpRA. A replay will be available on the AVITA Medical website, ...

BioCardia, Inc. (NASDAQ:BCDA), a micro-cap biotech company with a market value of $11.4 million, saw its President and CEO ...

In a recent transaction, Peter Altman, President and CEO of BioCardia, Inc. (NASDAQ:BCDA), purchased 600 shares of the company's common stock. The shares were acquired at an average price of $2.48 per ...

It is well known that HLA homozygous iPSCs are often selected to reduce adverse immune response in patients, however, there has recently been an increased demand for type O female blood-derived iPSCs.

The FDA published it three days later, on the 28th. The recalled products include 8-ounce packages of La Fiesta brand "Unseasoned Bread Crumbs (Pan Rayado)" and "Seasoned Bread Crumbs (Pan Rayado ...

Robert Vilahamn spoke to the media at Hotspur Way on Friday afternoon, ahead of our Barclays Women’s Super League clash against Manchester United at Tottenham Hotspur Stadium on Sunday (6.45pm UK).

In April this year Renalys submitted an Investigational New Drug (IND) Application for sparsentan to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan ... In 2023, Travere received FDA ...

TOKYO, Jan. 30, 2025 /PRNewswire/ -- Renalys Pharma, Inc. (Headquarters: Chuo-ku, Tokyo; "Renalys Pharma") announced today that it has completed patient enrollment for its registrational Phase III ...

In April 2024 Renalys submitted an Investigational New Drug (IND) Application for sparsentan to the Pharmaceuticals and Medical Devices Agency (PMDA) in Japan. The registrational Phase III study ...

YUCCA VALLEY — With a 44-point scoring spree in the first half, the varsity Wildcat basketball team beat the Yucca Valley Trojans for the second time this season Thursday, Jan. 23. The Wildcats ...